QUOTED. 11 November 2019. Thomas Zeller.
Executive Summary
Thomas Zeller of Germany’s Universitäts-Herzzentrum Freiburg-Bad Krozingen presented study data at the VIVA 2019 conference that showed peripheral artery disease (PAD) patients treated with paclitaxel-coated balloons for four years found good results – even in more complex cases. See what Zeller said here.
“Even in this real-world patient population, including those with critical limb ischemia, we continue to see durable treatment effect through four years. These data further demonstrate the clinical benefit of In.Pact Admiral DCB and its ability to be a first-line therapy for patients with challenging lesions.” – Thomas Zeller, director, Department of Angiology, Universitäts-Herzzentrum Freiburg-Bad Krozingen
Click here for a free trial of Medtech Insight